[Various immunologic indicators of cytostatic therapy in patients with malignant lymphoproliferative processes].
作者信息
Sakalová A, Drobná V, Hrubisková D
出版信息
Vnitr Lek. 1977 Jun;23(7):681-7.
PMID:331664
Abstract
摘要
相似文献
1
2
[Chemotherapy of multiple myeloma. Review of the recent trials].[多发性骨髓瘤的化疗。近期试验综述]
Recenti Prog Med. 1981 Aug;71(2):141-7.
3
[Treatment of Kahler's disease].
Sem Hop. 1976 Jan 16;52(3):165-71.
4
[Contribution of anthracyclines in treatment of lymphoproliferative disorders].[蒽环类药物在淋巴增生性疾病治疗中的作用]
Pathol Biol (Paris). 1987 Jan;35(1):75-8.
5
6
[Progress and results in the treatment of multiple myeloma].[多发性骨髓瘤的治疗进展与成果]
Bull Cancer. 1972 Oct-Dec;59(4):405-16.
7
[Chemotherapy of non-Hodgkin lymphomas].[非霍奇金淋巴瘤的化疗]
MMW Munch Med Wochenschr. 1980 Oct 31;122(44):1539-44.
8
[Guidelines in the therapy of various neoplastic diseases with cytostatic drugs].
Praxis. 1969 Jun 3;58(22):703-7.
9
10
An overview of the status of the nitrosoureas in other tumors.亚硝基脲类药物在其他肿瘤中的应用现状综述。
Cancer Chemother Rep 3. 1973 May;4(3):35-46.
Zotero 插件